Impending Ban on Bromated Flour Threatens Indian Bakery Industry and Consumer Prices

In the latest development of public health legislation, the Ministry of Health and Family Welfare, in concert with the Food Safety and Standards Authority of India, has tabled a draft amendment that would prohibit the use of bromated flour—an additive long celebrated for imparting elasticity and volume to wheat‑based products—on the grounds that it belongs to a class of compounds currently enumerated as probable carcinogens by leading international scientific bodies.

The commercial bakery sector across the Republic, which accounts for an estimated rupees thirty‑nine trillion in annual turnover and employs more than four million workers ranging from artisanal bakers to mechanised production line operators, has for decades relied upon the cost‑efficiency and functional advantages of bromated flour to meet the voracious demand for items such as soft rolls, crisp pizza bases, and the increasingly popular western‑style bagels that have found a foothold in metropolitan consumer markets.

Should the proposed prohibition take effect, preliminary cost modelling conducted by an independent consultancy suggests that the average retail price of a standard kilogram of wheat‑based bakery items could inflate by between eight and twelve percent, an increase that would be disproportionately borne by lower‑income households whose dietary patterns already allocate a substantial share of disposable income to staple foodstuffs.

The regulatory trajectory mirrors that of certain United States jurisdictions, where a comparable ban on bromated flour has been enacted under the auspices of the Food and Drug Administration, yet the Indian legislative process remains encumbered by protracted deliberations, inter‑ministerial consultations, and the requisite parliamentary approval that historically elongates the timeline for statutory implementation.

In response to the looming restriction, several leading bakery conglomerates have publicly announced exploratory procurement of alternative improvers, such as ascorbic acid and enzymatic blends, a strategic shift that would necessitate capital outlay for new mixing equipment, staff retraining programmes, and potential re‑engineering of product recipes, thereby introducing an additional layer of financial risk to an industry already contending with volatile wheat prices and fluctuating consumer confidence.

While the health advocacy community lauds the prospective removal of a chemical with documented associations to certain forms of gastrointestinal malignancies, it must be noted that the epidemiological evidence remains a matter of ongoing scholarly debate, and that a wholesale ban may inadvertently divert regulatory attention from more pervasive dietary hazards, such as excessive refined carbohydrate consumption and unchecked trans‑fat usage, which together constitute a far larger burden of disease in the Indian populace.

Consequently, the broader public policy implications of the draft amendment invite rigorous scrutiny, for it is incumbent upon legislators, regulators, and industry stakeholders alike to assess whether the envisaged prohibition merely substitutes one set of compliance costs for another, whether it substantiates its proclaimed health benefits through transparent risk‑benefit analysis, and whether it adequately safeguards the employment and purchasing power of citizens whose livelihoods depend upon affordable bakery products.

In light of these intertwined considerations, one might ask whether the present regulatory architecture possesses sufficient procedural safeguards to ensure that scientific uncertainty does not precipitate economically disruptive mandates, whether the statutory definitions of carcinogenicity applied to bromated flour are harmonised with global standards to prevent regulatory arbitrage, whether the government’s compensation mechanisms for affected workers and small‑scale entrepreneurs are adequately funded and promptly administered, whether the proposed ban is accompanied by a comprehensive transition framework that delineates clear timelines, technical assistance, and financial incentives for affected enterprises, and finally whether the ultimate public interest is served by a policy that prioritises symbolic prohibition over more substantive interventions aimed at improving overall nutritional outcomes and market transparency.

Published: May 11, 2026